Treatment

solution injectable/pour perfusion clinical trials

4 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A phase II study (GASPAR)
This study is testing a new combination of treatments for stomach cancer that can be removed with surgery. It combines a new drug, spartalizumab, with a standard chemotherapy (FLOT). Researchers want to see if this new combination helps shrink the cancer more before surgery and improves outcomes.
For: Resectable Gastric Cancer
France
Ongoing, recruitingTherapeutic confirmatory (Phase III)
Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome
This study is looking at different ways to sedate (keep calm) very sick patients in intensive care (ICU) who are at risk of a serious lung condition called ARDS. It compares inhaled sedation with standard methods to see if it helps lung function and overall recovery.
For: Patients in ICU with risks of Acute Respiratory Distress Syndrome
France
Ongoing, recruitingTherapeutic use (Phase IV)
Randomized controlled double-blind study ESKAPE : ESKetamine low-dose versus ketamine low-dose for Severe Acute Pain in Emergency Departments, comparison of PsychodyslEptic effects
This study is comparing two similar pain relief medicines, ketamine and esketamine, for severe sudden pain in accident and emergency. Researchers want to see if one causes fewer unusual side effects, like feeling strange or confused, while still being good at managing pain.
For: Severe acute pain
France
AuthorisedTherapeutic exploratory (Phase II)
PRODIGE 104 – NEOPREDICT A multicenter phase II trial using transcriptomic signatures to personalize neoadjuvant chemotherapy for patients with resectable borderline pancreatic adenocarcinoma.
This study looks at new ways to treat a specific type of pancreatic cancer that can be operated on. We're testing if personalising chemotherapy based on a patient's genes can improve treatment results and help people live longer and healthier lives.
For: Resectable borderline pancreatic adenocarcinoma
France

Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A phase II study (GASPAR)

Randomized Clinical Trial of Inhaled Sedation with Sevoflurane in Critically Ill Patients at Risk of Developing the Acute Respiratory Distress Syndrome

Randomized controlled double-blind study ESKAPE : ESKetamine low-dose versus ketamine low-dose for Severe Acute Pain in Emergency Departments, comparison of PsychodyslEptic effects

PRODIGE 104 – NEOPREDICT A multicenter phase II trial using transcriptomic signatures to personalize neoadjuvant chemotherapy for patients with resectable borderline pancreatic adenocarcinoma.